Amirreza Bitaraf

480 citations
20 papers · 334 indexed · h-index 12
Topics
MicroRNA in disease regulation (8 papers)Cancer-related molecular mechanisms research (8 papers)Circular RNAs in diseases (7 papers)

In The Last Decade

Amirreza Bitaraf

19 papers receiving 332 citations

Peers

Amirreza Bitaraf
Comparison fields: 5 of 59
  • Molecular Biology 260
  • Cancer Research 189
  • Rheumatology 36
  • Oncology 32
  • Genetics 27
Replace Kristofferson Tandoc with:
Kristofferson Tandoc Canada
Miro Viitala Finland
Dongli Zhao China
Chenfeng Wang China
Yun Gu China
Jing Lan China
Tommaso Selmi Italy
Mafalda Almeida Portugal
Amirreza Bitaraf relative to Kristofferson Tandoc Canada Kristofferson Tandoc's profile →
Citations per field
00.5×3.3×
Kristofferson Tandoc · 1×
Citations per year

Countries citing papers authored by Amirreza Bitaraf

Since Specialization
Citations

This map shows the geographic impact of Amirreza Bitaraf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amirreza Bitaraf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amirreza Bitaraf more than expected).

Fields of papers citing papers by Amirreza Bitaraf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amirreza Bitaraf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amirreza Bitaraf. The network helps show where Amirreza Bitaraf may publish in the future.

Co-authorship network of co-authors of Amirreza Bitaraf

This figure shows the co-authorship network connecting the top 25 collaborators of Amirreza Bitaraf. A scholar is included among the top collaborators of Amirreza Bitaraf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amirreza Bitaraf. Amirreza Bitaraf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 2
4 6
5 31
6 13
7 17
8 21
9 11
10 36
11 25
12 32
13 15
14 13
15 4
16 3
17 8
18 3
19 29
20 62

About Amirreza Bitaraf

Amirreza Bitaraf is a scholar working on Cancer Research, Developmental Neuroscience and Molecular Biology, having authored 20 papers that have together received 334 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (8 papers) and Circular RNAs in diseases (7 papers). The work is most often cited by research in Cancer Research (189 citations), Molecular Biology (260 citations) and Rheumatology (36 citations). Amirreza Bitaraf has collaborated with scholars based in Iran, United States and Australia. Frequent co-authors include Sadegh Babashah, Ehsan Razmara, Masoud Garshasbi, Hassan Yousefi, William C. Cho, Sadegh Babashah, Babak Bakhshinejad, Zahra Bahmanpour, Mohammad Taheri and Ladan Mashouri. Their work appears in journals such as International Journal of Molecular Sciences, Annals of the New York Academy of Sciences and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026